• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国立癌症研究所监测、流行病学和最终结果(SEER)项目中医院癌症病例报告的完整性。

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.

作者信息

Zippin C, Lum D, Hankey B F

机构信息

Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco 94143-0746, USA.

出版信息

Cancer. 1995 Dec 1;76(11):2343-50. doi: 10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#.

DOI:10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#
PMID:8635041
Abstract

BACKGROUND

To ascertain the quality of data entering a population-based reporting system, an essential requirement is to study levels of completeness of case-ascertainment and reporting. This study represents an effort to quantify completeness of case reporting in the SEER (Surveillance, Epidemiology, and End Results) Program of the National Cancer Institute.

METHODS

Hospitals in each of the participating SEER areas were stratified according to their annual hospital cancer caseload for the year 1987. Within each caseload stratum, a random sample of hospitals was selected for inclusion in this study. Files in the medical record, pathology, and radiation oncology departments in each hospital were reviewed for SEER reportable cases. These cases were then matched against SEER case listings to identify unreported cases.

RESULTS

The crude estimated completeness of reporting for 1987 in the six participating SEER areas was 97.7% and the registry-caseload standardized rate was 96.8%. Variation was noted by SEER registry, hospital cancer caseload, and casefinding source (hospital department). Three-quarters of unreported cases were of invasive disease and one-fourth were in situ, primarily of the cervix uteri.

CONCLUSIONS

There is variation in completeness of casefinding among SEER registries, hospital size, and hospital department source. Additional factors that appear to be related to case ascertainment are cancer site or type and who performs the casefinding function (hospital registry or central registry staff).

摘要

背景

为确定进入基于人群的报告系统的数据质量,一项基本要求是研究病例确诊和报告的完整程度。本研究旨在对美国国立癌症研究所的监测、流行病学和最终结果(SEER)计划中的病例报告完整性进行量化。

方法

根据1987年各参与SEER地区医院的年度癌症病例数对医院进行分层。在每个病例数分层内,随机抽取医院样本纳入本研究。对每家医院的病历、病理和放射肿瘤学部门的档案进行审查,以查找SEER可报告病例。然后将这些病例与SEER病例清单进行比对,以识别未报告的病例。

结果

1987年六个参与SEER地区报告的粗略估计完整性为97.7%,登记处病例数标准化率为96.8%。不同SEER登记处、医院癌症病例数和病例发现来源(医院科室)存在差异。四分之三未报告的病例为浸润性疾病,四分之一为原位癌,主要是子宫颈原位癌。

结论

SEER登记处、医院规模和医院科室来源之间的病例发现完整性存在差异。似乎与病例确诊相关的其他因素是癌症部位或类型以及进行病例发现工作的人员(医院登记员或中央登记处工作人员)。

相似文献

1
Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.美国国立癌症研究所监测、流行病学和最终结果(SEER)项目中医院癌症病例报告的完整性。
Cancer. 1995 Dec 1;76(11):2343-50. doi: 10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#.
2
Study of completeness of the surveillance, epidemiology and end results (SEER) program case ascertainment by hospital size and casefinding source.按医院规模和病例发现来源对监测、流行病学和最终结果(SEER)计划病例确诊完整性的研究。
Health Rep. 1993;5(1):87-90.
3
Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.2011 - 2015年加拿大癌症登记处非恶性中枢神经系统肿瘤的病例完整性
J Registry Manag. 2018 Fall;45(1):117-131.
4
Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.近期添加到监测、流行病学与最终结果数据库(SEER)中的临床和预后变量中缺失数据的频率及决定因素。
J Registry Manag. 2011 Autumn;38(3):120-31.
5
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.基于监测、流行病学和最终结果(SEER)计划中肿瘤登记数据的癌症患病率估计。
Int J Epidemiol. 2000 Apr;29(2):197-207. doi: 10.1093/ije/29.2.197.
6
Improving case ascertainment of a population-based birth defects registry in New York State using hospital discharge data.利用医院出院数据改善纽约州基于人群的出生缺陷登记处的病例确诊情况。
Birth Defects Res A Clin Mol Teratol. 2005 Oct;73(10):663-8. doi: 10.1002/bdra.20208.
7
Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).监测、流行病学与最终结果(SEER)18数据库(2004 - 2012年,各年份不同)中脑和中枢神经系统肿瘤所需特定部位因素的完整性
J Neurooncol. 2016 Oct;130(1):31-42. doi: 10.1007/s11060-016-2217-7. Epub 2016 Jul 14.
8
Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).构建全国癌症监测与控制基础设施——国家癌症登记项目(NPCR)与监测、流行病学和最终结果(SEER)项目(美国)之比较
Cancer Causes Control. 2003 Mar;14(2):175-93. doi: 10.1023/a:1023002322935.
9
Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.评估与2000年监测、流行病学和最终结果(SEER)总结分期不明相关的因素,该分期由中央登记处层面的协作分期得出。
J Registry Manag. 2012 Fall;39(3):101-6.
10
Reporting cutaneous melanoma to cancer registries in the United States.向美国癌症登记处报告皮肤黑色素瘤。
J Am Acad Dermatol. 2003 Oct;49(4):624-30. doi: 10.1067/s0190-9622(03)00885-5.

引用本文的文献

1
Anti-Obesity Medications and the Risk of Obesity-Related Cancers in Older Women: A Propensity Score Matching Analysis of 2007-2015 SEER-Medicare Data.抗肥胖药物与老年女性肥胖相关癌症风险:对2007 - 2015年监测、流行病学和最终结果(SEER)-医疗保险数据的倾向评分匹配分析
Cancers (Basel). 2025 May 11;17(10):1624. doi: 10.3390/cancers17101624.
2
Inequality in Female Breast Cancer Relative Survival Rates between White and Black Women in the United States.美国白人和黑人女性乳腺癌相对生存率的不平等。
J Racial Ethn Health Disparities. 2024 Jul 3. doi: 10.1007/s40615-024-02079-w.
3
Disparities in Access to Liver Transplant Referral and Evaluation among Patients with Hepatocellular Carcinoma in Georgia.
佐治亚州肝细胞癌患者在肝移植转诊和评估方面的差异。
Cancer Res Commun. 2024 Apr 22;4(4):1111-1119. doi: 10.1158/2767-9764.CRC-23-0541.
4
The changes of subtype markers between first and second primary breast cancers.首次和二次原发性乳腺癌之间亚型标志物的变化。
Cancer Med. 2023 Jun;12(12):13649-13660. doi: 10.1002/cam4.5979. Epub 2023 Apr 25.
5
Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.老年人中使用减肥药物与前列腺癌、结直肠癌和男性乳腺癌的关系:SEER-医疗保险 2007-2015 年。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8255-8265. doi: 10.1007/s00432-023-04778-z. Epub 2023 Apr 17.
6
Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors.长期癌症幸存者中心血管疾病死亡率高于癌症死亡率。
Front Cardiovasc Med. 2023 Jan 25;10:1014400. doi: 10.3389/fcvm.2023.1014400. eCollection 2023.
7
Survival nomogram for endometrial cancer with lung metastasis: A SEER database analysis.子宫内膜癌肺转移生存列线图:一项监测、流行病学和最终结果(SEER)数据库分析
Front Oncol. 2022 Oct 7;12:978140. doi: 10.3389/fonc.2022.978140. eCollection 2022.
8
Hospitalization and Mortality Outcomes Among Childhood Cancer Survivors by Race, Ethnicity, and Time Since Diagnosis.儿童癌症幸存者的住院和死亡率与种族、民族和诊断后时间的关系。
JAMA Netw Open. 2022 Jun 1;5(6):e2219122. doi: 10.1001/jamanetworkopen.2022.19122.
9
Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage.2000 年至 2018 年期间,按时间段、年龄和肿瘤分期比较美国 20 岁及以上亚洲女性与其他族裔女性的乳腺癌发病率趋势。
Cancer Epidemiol. 2022 Feb;76:102076. doi: 10.1016/j.canep.2021.102076. Epub 2021 Nov 30.
10
The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.睾酮替代疗法和他汀类药物的作用及其联合应用在前列腺癌中的作用。
Cancer Causes Control. 2021 Sep;32(9):965-976. doi: 10.1007/s10552-021-01450-0. Epub 2021 May 26.